Variant report

Variant	esv3403825
Chromosome Location	chr19:39646612-39650810
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr19:39647436-39647807	GM12878	blood:	n/a	n/a
2	BCL3	chr19:39648476-39649104	GM12878	blood:	n/a	n/a
3	BCL3	chr19:39647464-39647770	GM12878	blood:	n/a	n/a
4	BCL3	chr19:39648488-39649059	GM12878	blood:	n/a	n/a
5	CHD2	chr19:39646727-39646728	K562	blood:	n/a	n/a
6	CTCF	chr19:39648753-39648808	MCF-7	breast:	n/a	n/a
7	CTCF	chr19:39648260-39648410	HCPEpiC	choroid plexus:	n/a	n/a
8	CTCF	chr19:39648712-39648754	GM19239	blood:	n/a	n/a
9	CTCF	chr19:39648809-39648816	MCF-7	breast:	n/a	n/a
10	CTCF	chr19:39648755-39648890	GM19239	blood:	n/a	n/a
11	CTCF	chr19:39648756-39648853	MCF-7	breast:	n/a	n/a
12	CTCF	chr19:39648100-39648250	AoAF	blood vessel:	n/a	n/a
13	CTCF	chr19:39648748-39648837	H1-hESC	embryonic stem cell:	n/a	n/a
14	EGR1	chr19:39647111-39647475	K562	blood:	n/a	chr19:39647251-39647261 chr19:39647463-39647472 chr19:39647174-39647184
15	EGR1	chr19:39647166-39647406	K562	blood:	n/a	chr19:39647251-39647261 chr19:39647174-39647184
16	ELF1	chr19:39647267-39647573	K562	blood:	n/a	n/a
17	EP300	chr19:39650767-39651552	MCF-7	breast:	n/a	chr19:39650823-39650836
18	FOXA1	chr19:39648297-39648566	T-47D	breast:	n/a	n/a
19	GATA3	chr19:39650734-39651520	MCF-7	breast:	n/a	chr19:39651490-39651500
20	HDAC2	chr19:39650783-39651431	MCF-7	breast:	n/a	n/a
21	MAX	chr19:39649327-39649637	K562	blood:	n/a	n/a
22	MAX	chr19:39646955-39647811	MCF-7	breast:	n/a	chr19:39647210-39647220 chr19:39647210-39647221 chr19:39647210-39647221 chr19:39647209-39647222 chr19:39647211-39647221 chr19:39647209-39647222 chr19:39647206-39647225 chr19:39647211-39647220 chr19:39647210-39647221 chr19:39647210-39647220 chr19:39647209-39647222 chr19:39647211-39647221
23	MAX	chr19:39650611-39651583	MCF-7	breast:	n/a	n/a
24	MAX	chr19:39647720-39648624	HepG2	liver:	n/a	n/a
25	MAX	chr19:39648784-39648937	HepG2	liver:	n/a	n/a
26	MAX	chr19:39646980-39647257	K562	blood:	n/a	chr19:39647210-39647220 chr19:39647210-39647221 chr19:39647210-39647221 chr19:39647209-39647222 chr19:39647211-39647221 chr19:39647209-39647222 chr19:39647206-39647225 chr19:39647211-39647220 chr19:39647210-39647221 chr19:39647210-39647220 chr19:39647209-39647222 chr19:39647211-39647221
27	MAZ	chr19:39647020-39648140	IMR90	lung:	n/a	chr19:39647210-39647220 chr19:39647210-39647221 chr19:39647210-39647221 chr19:39647209-39647222 chr19:39647211-39647221 chr19:39647209-39647222 chr19:39647206-39647225 chr19:39647211-39647220 chr19:39647210-39647221 chr19:39647210-39647220 chr19:39647209-39647222 chr19:39647211-39647221
28	MYC	chr19:39648720-39648768	MCF-7	breast:	n/a	n/a
29	MYC	chr19:39648711-39648970	MCF-7	breast:	n/a	n/a
30	MYC	chr19:39648710-39648960	MCF-7	breast:	n/a	n/a
31	MYC	chr19:39647244-39647330	MCF-7	breast:	n/a	n/a
32	MYC	chr19:39647178-39647184	MCF-7	breast:	n/a	n/a
33	MYC	chr19:39647456-39647458	MCF-7	breast:	n/a	n/a
34	MYC	chr19:39648704-39648712	MCF-7	breast:	n/a	n/a
35	MYC	chr19:39648427-39648523	HepG2	liver:	n/a	n/a
36	MYC	chr19:39648387-39648423	HepG2	liver:	n/a	n/a
37	MYC	chr19:39648771-39648778	MCF-7	breast:	n/a	n/a
38	MYC	chr19:39648691-39648695	MCF-7	breast:	n/a	n/a
39	MYC	chr19:39647519-39647627	MCF-7	breast:	n/a	n/a
40	MYC	chr19:39648820-39648847	HUVEC	blood vessel:	n/a	n/a
41	MYC	chr19:39647229-39647237	MCF-7	breast:	n/a	n/a
42	MYC	chr19:39648531-39648875	MCF-7	breast:	n/a	n/a
43	MYC	chr19:39648780-39648783	MCF-7	breast:	n/a	n/a
44	MYC	chr19:39647467-39647598	MCF-7	breast:	n/a	n/a
45	MYC	chr19:39649063-39649110	GM12878	blood:	n/a	n/a
46	MYC	chr19:39648640-39648815	HUVEC	blood vessel:	n/a	n/a
47	MYC	chr19:39647331-39647333	MCF-7	breast:	n/a	n/a
48	NFATC1	chr19:39648443-39649150	GM12878	blood:	n/a	n/a
49	NFATC1	chr19:39648474-39649114	GM12878	blood:	n/a	n/a
50	NR2F2	chr19:39650798-39651437	MCF-7	breast:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:39649335..39651223-chr19:39816830..39818600,2	MCF-7	breast:
2	chr19:39649401..39653814-chr19:39654605..39660099,7	K562	blood:
3	chr19:39643758..39646287-chr19:39649616..39652008,3	K562	blood:
4	chr19:39645610..39647317-chr19:39897484..39899400,2	MCF-7	breast:
5	chr19:39644386..39647038-chr19:39665325..39668037,2	MCF-7	breast:
6	chr19:39615259..39630637-chr19:39640467..39653924,38	MCF-7	breast:

Variant related genes	Relation type
PAK4	TF binding region
ENSG00000130669	chromatin interactions
ENSG00000128016	chromatin interactions
ENSG00000269172	chromatin interactions

Extended variants
information (count: 199 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:199 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs554623512	chr19:39646615-39646616	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs144420731	chr19:39646625-39646626	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs543405508	chr19:39646684-39646685	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs184751483	chr19:39646697-39646698	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs533080643	chr19:39646728-39646729	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs188812003	chr19:39646729-39646730	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs545260574	chr19:39646739-39646740	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs560106437	chr19:39646757-39646758	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs527468860	chr19:39646769-39646770	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs549144283	chr19:39646796-39646797	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs374561760	chr19:39646819-39646820	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs559709279	chr19:39646825-39646826	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs192196840	chr19:39646923-39646924	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs12979746	chr19:39646939-39646940	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs146599109	chr19:39646947-39646948	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs549514427	chr19:39646964-39646965	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs571191207	chr19:39646981-39646982	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs538975900	chr19:39646982-39646983	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs371832656	chr19:39647014-39647015	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs12978175	chr19:39647015-39647016	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs565959121	chr19:39647028-39647029	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs543780674	chr19:39647033-39647034	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs554686845	chr19:39647127-39647128	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs576141135	chr19:39647128-39647129	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs12978880	chr19:39647136-39647137	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs5828032	chr19:39647143-39647144	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs112795733	chr19:39647250-39647251	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs543852483	chr19:39647253-39647254	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs3889485	chr19:39647255-39647256	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs577136988	chr19:39647266-39647267	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs691080	chr19:39647284-39647285	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs560391674	chr19:39647311-39647312	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs570038912	chr19:39647312-39647313	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs542853458	chr19:39647318-39647319	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs185415567	chr19:39647321-39647322	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs750247	chr19:39647356-39647357	Weak transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs548980897	chr19:39647418-39647419	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs549811747	chr19:39647429-39647430	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs564760337	chr19:39647442-39647443	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs532109500	chr19:39647500-39647501	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs189526884	chr19:39647508-39647509	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs566025121	chr19:39647525-39647526	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs536510432	chr19:39647573-39647574	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs548380537	chr19:39647658-39647659	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs567394242	chr19:39647672-39647673	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs569887417	chr19:39647703-39647704	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs181585281	chr19:39647719-39647720	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs558995028	chr19:39647722-39647723	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs577198316	chr19:39647727-39647728	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs185757615	chr19:39647741-39647742	Enhancers Genic enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Wilms tumour	21544195	CNVD
Mental retardation	19951919	CNVD
19q13.11 deletion syndrome	22378287	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Lung cancer	21569311	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21240255	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:384 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:39617400-39659800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
2	chr19:39624000-39647000	Weak transcription	NHLF	lung
3	chr19:39627200-39646800	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
4	chr19:39630800-39646800	Weak transcription	Osteobl	bone
5	chr19:39630800-39651000	Weak transcription	NHDF-Ad	bronchial
6	chr19:39631000-39660000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
7	chr19:39635400-39647000	Weak transcription	Muscle Satellite Cultured Cells	--
8	chr19:39635600-39647000	Weak transcription	NH-A	brain
9	chr19:39635600-39647400	Weak transcription	Primary T helper cells PMA-I stimulated	--
10	chr19:39636000-39647400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr19:39636000-39668200	Weak transcription	Primary B cells from cord blood	blood
12	chr19:39636400-39665600	Weak transcription	Aorta	Aorta
13	chr19:39636800-39650800	Weak transcription	HUVEC	blood vessel
14	chr19:39637000-39653600	Weak transcription	Brain Germinal Matrix	brain
15	chr19:39637200-39647000	Weak transcription	Small Intestine	intestine
16	chr19:39637400-39647400	Weak transcription	Rectal Smooth Muscle	rectum
17	chr19:39637400-39660800	Weak transcription	Primary hematopoietic stem cells	blood
18	chr19:39638000-39646800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
19	chr19:39638000-39661400	Weak transcription	H9 Cell Line	embryonic stem cell
20	chr19:39638200-39648600	Weak transcription	Brain Angular Gyrus	brain
21	chr19:39640000-39647600	Weak transcription	HSMMtube	muscle
22	chr19:39640000-39648400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr19:39640000-39672600	Weak transcription	GM12878-XiMat	blood
24	chr19:39640200-39647400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr19:39640200-39647400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr19:39640200-39660000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr19:39641200-39649200	Weak transcription	Fetal Brain Female	brain
28	chr19:39642000-39649600	Enhancers	Placenta	Placenta
29	chr19:39642200-39647400	Weak transcription	Right Atrium	heart
30	chr19:39642400-39647000	Weak transcription	HSMM	muscle
31	chr19:39642400-39649000	Weak transcription	Thymus	Thymus
32	chr19:39643400-39648200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr19:39644200-39652200	Enhancers	Placenta Amnion	Placenta Amnion
34	chr19:39644400-39647400	Enhancers	Liver	Liver
35	chr19:39644400-39648800	Enhancers	Gastric	stomach
36	chr19:39644400-39649600	Enhancers	Pancreas	Pancrea
37	chr19:39644400-39651800	Genic enhancers	Fetal Intestine Small	intestine
38	chr19:39644600-39647200	Enhancers	Colonic Mucosa	Colon
39	chr19:39644600-39647200	Enhancers	HMEC	breast
40	chr19:39644600-39647400	Enhancers	Rectal Mucosa Donor 31	rectum
41	chr19:39644600-39647800	Enhancers	H1 Cell Line	embryonic stem cell
42	chr19:39644600-39647800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr19:39644600-39648400	Enhancers	Sigmoid Colon	Sigmoid Colon
44	chr19:39644600-39648600	Enhancers	Duodenum Mucosa	Duodenum
45	chr19:39644600-39648600	Enhancers	Fetal Heart	heart
46	chr19:39644600-39649000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr19:39644600-39649400	Enhancers	Breast Myoepithelial Primary Cells	Breast
48	chr19:39644600-39649400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
49	chr19:39644600-39649400	Enhancers	Lung	lung
50	chr19:39644600-39649600	Enhancers	K562	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links